← SynDRA
KENPAULLONE
SynDRA canonical compound SYN0002459 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CDK1 |
|---|
| Mechanism of action | GSK-3 inhibitor |
|---|
All known targets
- GSK3B
- CDK1
- CDK5
- CCNB1
- CDK2
- GSK3A
- LCK
- Malaria Pfmrk
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
- GSK-3 inhibitor
- GSK3B INHIBITOR
- glycogen synthase kinase inhibitor
- CDK1 INHIBITOR
- Inhibitor
- CCNB1 INHIBITOR
- CDK5 INHIBITOR
- GSK3A INHIBITOR
Cross-references
Synonyms
- 9-Bromopaullone
- NSC-664704
- 9-Bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
- NSC664704
- MLS002702152
- CHEMBL296586
- 9-Bromo-7,12-dihydroindolo(3,2-d)(1)benzazepin-6(5H)-one
- Indolo[3,2-d][1]benzazepin-6(5H)-one,9-bromo-7,12-dihydro-
- QQUXFYAWXPMDOE-UHFFFAOYSA-N
- 9-Bromo-7,12-dihydro-indolo[3,2-d][1]benzazepin-6(5H)-one
- 9-bromo-7,12-dihydro-5H-indolo[3,2-d][1]benzazepin-6-one
- 9-Bromo-7,12-dihydro-indolo-[3,2-d]-[1]benzazepin-6(5H)-one
- 9-bromo-7,12-dihydrobenzo[2,3]azepino[4,5-b]indol-6(5H)-one
- 9-Bromopaullone;NSC-664704
- Indolo[3,2-d][1]benzazepin-6(5H)-one, 9-bromo-7,12-dihydro-
- C16H11BrN2O
- NSC-664704(Kenpaullone)
- SR-01000075952
- Bromo Paullone
- MFCD02683595
- Kinome_3565
- Tocris-1398
- Kenpaullone, >=98%
- BiomolKI_000072
- Lopac-K-3888
- BiomolKI2_000076
- NCIMech_000735
- cid_3820
- Lopac0_000647
- SCHEMBL79889
- BDBM7266
- GTPL6000
- STO175
- T72H2BL53P
- CHEBI:92658
- DTXSID10161994
- EX-A702
- BCPP000195
Look up KENPAULLONE in the interactive SynDRA portal →